Picture of Biomerieux SA logo

BIM — Biomerieux SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Corrected: Biomérieux third-quarter sales grew more than expected

CORRECTED-Biomérieux third-quarter sales grew more than expected 

Corrects consensus figure to million from billion

- French biotechnology firm Biomérieux BIOX.PA reported on Tuesday a better-than-expected organic sales growth in the third quarter, helped by a 13% increase in sales from GO 28 growth drivers.

Total sales for the period came in at €1,042 million ($1.17 billion), up 8% year on year, above the company's compiled median consensus for sales of €1,007 million (not billion) and organic growth of 5.9%.

($1 = 0.8937 euros)


(Reporting by Margaux Perrin in Gdansk, editing by Izabela Niemiec)

((Margaux.Perrin@thomsonreuters.com ))

Recent news on Biomerieux SA

See all news